May 06, 2026

Caris Life Sciences Launches Caris MI Clarity, the First and Only AI-Powered Test to Predict Both Early and Late Distant Recurrence Risk in Breast Cancer at the Time of Diagnosis

Caris MI Clarity leverages AI to transform how recurrence risk is understood and applied in postmenopausal patients with HR-positive/HER2-negative, node-negative early-stage breast cancer IRVING, Texas, May 5, 2026 /PRNewswire/ -- Caris Life Sciences®...

recent articles

My father used to say "You can get anything you need at a hardware store." I used to love going with him to the local Ace Hardware and getting the special screws or bolts and tools for a particular project. The smell, the merchandise packed...

Marie-Louise Loupart, Digital Pathology Software Specialist – Leica Biosystems LEARN MORE Today, we are surrounded by Artificial Intelligence (AI) and often don’t even know it’s there. AI systems make headlines when something goes...

Marie-Louise Loupart, Digital Pathology Software Specialist Learn More Here Previously, we have examined uses for pattern recognition in brightfield images. Let us focus on what it can do for fluorescent applications. Machine...

OR

platinum partners

gold partners

Silver Partners

Media Partners